Virla, Federica
Turano, Ermanna
Scambi, Ilaria
Schiaffino, Lorenzo
Boido, Marina
Mariotti, Raffaella http://orcid.org/0000-0001-7392-6689
Article History
Received: 30 May 2023
Accepted: 8 March 2024
First Online: 1 April 2024
Change Date: 29 April 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13287-024-03744-x
Declarations
:
: The manuscript has been organized following the Animal Research: Reporting of in Vivo Experiments (ARRIVE) guidelines in order to improve the reporting of research involving animals and to optimize quality and reproducibility of published research. All mouse experiments used to isolate ASCs were carried out in strict accordance with experimental guidelines approved by the University of Verona committee on animal research (Centro Interdipartimentale di Servizio alla Ricerca Sperimentale) and by the Italian Ministry of Health (protocol #642/2021-PR, title of approved project “New therapeutical approach for ALS”). The experimental procedures involving live SMNΔ7 animals were performed in strict accordance with institutional guidelines in compliance with national (D.L. N.26, 04/03/2014) and international law and policies (new directive 2010/63/EU). The study was approved by the Italian Ministry of Health (protocol #980/2020-PR, title “Evaluation of the effectiveness of SMN-dependent and SMN-independent therapies to counteract Spinal Muscular Atrophy”). Additionally, the ad hoc Ethical Committee of the University of Turin approved this study. All mice were sacrificed by cervical dislocation or transcardically perfused after being deeply anesthetized by gaseous anaesthesia (See section). All methods were completed and reported in accordance with the ARRIVE guidelines. The research complies with the commonly accepted “3Rs”, minimizing the number of animals used and avoiding their suffering.
: Not applicable.
: The authors declare that they have no competing interests.